cyclopentane has been researched along with olaparib in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Guo, ZP; Hu, YC; Jin, F; Liu, XD; Ma, T; Song, ZQ; Xie, Y; Zhou, PK | 1 |
1 other study(ies) available for cyclopentane and olaparib
Article | Year |
---|---|
MLN4924 suppresses the BRCA1 complex and synergizes with PARP inhibition in NSCLC cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; BRCA1 Protein; Carcinoma, Non-Small-Cell Lung; Carrier Proteins; Cell Line, Tumor; Cyclopentanes; DNA Damage; DNA-Binding Proteins; Histone Chaperones; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Multiprotein Complexes; NEDD8 Protein; Nuclear Proteins; Phthalazines; Piperazines; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Pyrimidines; Tumor Suppressor Proteins; Ubiquitin-Protein Ligases; Ubiquitins | 2017 |